Clinical Trials

This page contains information about the Clinical Trials data source in the Dimensions BigQuery project.

See also

Dimensions DSL API Documentation for this type is also available from here.

Clinical Trials Schema

Field

Type

Description

Example

abstract

Literal: String

Abstract or description of the clinical trial.

 
      "Adolescent young carers (AYCs) are young people aged 15-17 years old, who take on significant or substantial caring tasks and assume a level of responsibility that would usually be associated with an adult. In Europe, the estimated prevalence rate of YCs is around 4-8%.Taking on care responsibilities so early in life may have considerable negative consequences for YCs' mental and physical health and psychosocial development. Psychosocial interventions to support YC worldwide are generally quite limited. The H2020 Me-We project (Psychosocial Support for Promoting Mental Health and Well-being among Adolescent Young Carers in Europe) aims to develop an innovative framework of primary prevention interventions for adolescent YCs (AYCs) aged 15-17 to be tested in six European countries (Italy, Netherlands, Slovenia, Sweden, Switzerland, United Kingdom). The theoretical framework chosen for the intervention is the DNA-V Model. The DNA-V model is a psychological intervention, addressed to adolescents and young people, used in educational and clinical settings. This model has its roots in the contextual and functional science and it is based on Acceptance and Commitment Therapy, a third-generation cognitive-behavioural therapy. The intervention programme designed for the ME-WE project builds on the DNA-V model but it was adapted to fit the specific needs of adolescent young carers (AYCs) and the goals of the ME-WE project. The study aim is to evaluate the efficacy of DNA-V based program for AYCs (so-called ME-WE intervention), using a cluster-randomized controlled trial (C-RCT) design. The evaluation of the intervention will be carried out using as primary outcome variables: Psychological flexibility; Mindfulness skills; Resilience; Subjective mental health; Quality of life; Subjective health complaints; Caring-related quality of life; Cognitive and emotional impact of caring and Social support. As secondary outcome variables will be included Self-reported school, training or work experience, performance, and attendance.\n\nDetailed Description\nAdolescent young carers (AYCs) are young people aged 15-17 years old, who take on significant or substantial caring tasks and assume a level of responsibility that would usually be associated with an adult. Often on a regular basis, they look after family member(s) with a disability, chronic physical and/or mental health condition or substance use issue and/or problems related to old age, who require support or supervision. In Europe, the estimated prevalence rate of YCs is around 4-8%. Taking on care responsibilities so early in life may have considerable negative consequences for YCs' mental and physical health and psychosocial development. Furthermore, YCs likely face difficulties in education that negatively impact their future employability and socio-economic status and experience constraints in finding and maintaining employment and pursuing their career aspirations. Psychosocial interventions to support YC worldwide are generally quite limited. In order to prevent the entrenched level of caring that results in significant and long-term effects on YCs' well-being and hinder transitions to adulthood, it has been suggested that a primary prevention model should be adopted. To prevent adverse mental health, social, and educational outcomes in YCs, building their resilience would be especially important. The H2020 Me-We project (Psychosocial Support for Promoting Mental Health and Well-being among Adolescent Young Carers in Europe) aims to develop an innovative framework of primary prevention interventions for adolescent YCs (AYCs) aged 15-17 to be tested in six European countries (Italy, Netherlands, Slovenia, Sweden, Switzerland, United Kingdom). The theoretical framework chosen for the intervention is the DNA-V Model. The DNA-V model is a psychological intervention, addressed to adolescents and young people, used in educational and clinical settings. This model has its roots in the contextual and functional science and it is based on Acceptance and Commitment Therapy, a third-generation cognitive-behavioural therapy. The intervention programme designed for the ME-WE project builds on the DNA-V model but it was adapted to fit the specific needs of adolescent young carers (AYCs) and the goals of the ME-WE project. The study aim is to evaluate the efficacy of DNA-V-based program for AYCs, called the ME-WE support intervention, using a cluster-randomized controlled trial (C-RCT) design. The evaluation of the intervention will be carried out using as primary outcome variables: Psychological flexibility; Mindfulness skills; Resilience; Subjective mental health; Quality of life; Subjective health complaints; Caring-related quality of life; Cognitive and emotional impact of caring and Social support. As secondary outcome variables Self-reported school, training or work experience, performance, and attendance will be used. Control variable will be caring activities; overall amount of caring and likes and dislikes about caring. Results will be compared of the intervention-group participants relative to the wait-list control-group participants from baseline (pre-intervention) through post-intervention and 3-month follow-up (3MFU). Investigators expect that there will be greater improvements in protective factors targeted by the ME-WE intervention. Thus, it is hypothesized that, compared to the wait-list control group, ME-WE participants will report greater improvements in psychological flexibility, mindfulness, resilience, subjective mental health and quality of life as well as in perceived emotional impact of caring and social support (primary outcomes), and these effects will be maintained at the 3MFU. The impact of ME-WE on self-reported school, training or work experience, performance, and attendance of AYCs (secondary outcomes) will be also explored. Since the intervention will not address these variables directly, we consider them as secondary outcomes."

acronym

Literal: String

Acronym of the clinical trial.

 
      "ME-WE"

active_years

Array of < Literal: Integer >

List of active years for a clinical trial.

 
      [2019, 2020, 2021]

altmetrics

Entity: Altmetric

If available, Altmetric details relating to the clinical trial.

 
      {"id": "75045719", "score": 128}

associated_grant_ids

Array of < Literal: String >

Dimensions IDs of the grants associated to the clinical trial.

 
      ["grant.6443089", "grant.2690176", "grant.6499358"]

brief_title

Literal: String

Brief title of the clinical trial.

 
      "A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers:"

categories

Entity: VersionedCategories

Versioned categorisations.

 
      {"bra_v1": {"values": ["Public Health"], "full": [{"id": "4003", "value": "Public Health"}]}, "for_v1": {"first_level": {"codes": ["11", "13", "17"], "full": [{"id": "2211", "code": "11", "name": "Medical and Health Sciences"}, {"id": "2213", "code": "13", "name": "Education"}, {"id": "2217", "code": "17", "name": "Psychology and Cognitive Sciences"}]}, "second_level": {"codes": ["1303", "1117", "1701"], "full": [{"id": "3268", "code": "1303", "name": "Specialist Studies In Education"}, {"id": "3177", "code": "1117", "name": "Public Health and Health Services"}, {"id": "3468", "code": "1701", "name": "Psychology"}]}}, "hra_v1": {"values": ["Population & Society"], "full": [{"id": "3903", "value": "Population & Society"}]}, "hrcs_hc_v1": {"values": ["Mental Health"], "full": [{"id": "905", "value": "Mental Health"}]}, "hrcs_rac_v1": {"codes": ["6.6", "7.1"], "full": [{"id": "10606", "code": "6.6", "name": "Psychological and behavioural"}, {"id": "10701", "code": "7.1", "name": "Individual care needs"}]}, "icrp_cso_v1": {"codes": ["6.6", "6.5", "6.3", "6.1", "6.9"], "full": [{"id": "3777", "code": "6.6", "name": "End-of-Life Care"}, {"id": "3776", "code": "6.5", "name": "Education and Communication"}, {"id": "3774", "code": "6.3", "name": "Behavior"}, {"id": "3772", "code": "6.1", "name": "Patient Care and Survivorship Issues"}, {"id": "3780", "code": "6.9", "name": "Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Research"}]}, "icrp_ct_v1": {"values": ["Not Site-Specific Cancer"], "full": [{"id": "3816", "value": "Not Site-Specific Cancer"}]}, "rcdc_v1": {"values": ["Prevention", "Clinical Trials and Supportive Activities", "Behavioral and Social Science", "Mind and Body", "Mental Health", "Clinical Research", "Complementary and Alternative Medicine", "Pediatric"], "full": [{"id": "558", "value": "Prevention"}, {"id": "508", "value": "Clinical Trials and Supportive Activities"}, {"id": "498", "value": "Behavioral and Social Science"}, {"id": "458", "value": "Mind and Body"}, {"id": "380", "value": "Mental Health"}, {"id": "507", "value": "Clinical Research"}, {"id": "430", "value": "Complementary and Alternative Medicine"}, {"id": "547", "value": "Pediatric"}]}, "sdg_v1": null, "uoa_v1": {"codes": ["A03"], "full": [{"id": "30003", "code": "A03", "name": "Allied Health Professions, Dentistry, Nursing and Pharmacy"}]}}

category_bra

Entity: SimpleCategorization

Broad Research Areas

 
      {"values": ["Public Health"], "full": [{"id": "4003", "value": "Public Health"}]}

category_for

Entity: ComplexSystematicCategorization

ANZSRC Fields of Research classification

 
      {"first_level": {"codes": ["11", "13", "17"], "full": [{"id": "2211", "code": "11", "name": "Medical and Health Sciences"}, {"id": "2213", "code": "13", "name": "Education"}, {"id": "2217", "code": "17", "name": "Psychology and Cognitive Sciences"}]}, "second_level": {"codes": ["1303", "1117", "1701"], "full": [{"id": "3268", "code": "1303", "name": "Specialist Studies In Education"}, {"id": "3177", "code": "1117", "name": "Public Health and Health Services"}, {"id": "3468", "code": "1701", "name": "Psychology"}]}}

category_hra

Entity: SimpleCategorization

Health Research Areas

 
      {"values": ["Population & Society"], "full": [{"id": "3903", "value": "Population & Society"}]}

category_hrcs_hc

Entity: SimpleCategorization

HRCS - Health Categories

 
      {"values": ["Mental Health"], "full": [{"id": "905", "value": "Mental Health"}]}

category_hrcs_rac

Entity: SystematicCategorization

HRCS – Research Activity Codes

 
      {"codes": ["6.6", "7.1"], "full": [{"id": "10606", "code": "6.6", "name": "Psychological and behavioural"}, {"id": "10701", "code": "7.1", "name": "Individual care needs"}]}

category_icrp_cso

Entity: SystematicCategorization

ICRP Common Scientific Outline

 
      {"codes": ["6.6", "6.5", "6.3", "6.1", "6.9"], "full": [{"id": "3777", "code": "6.6", "name": "End-of-Life Care"}, {"id": "3776", "code": "6.5", "name": "Education and Communication"}, {"id": "3774", "code": "6.3", "name": "Behavior"}, {"id": "3772", "code": "6.1", "name": "Patient Care and Survivorship Issues"}, {"id": "3780", "code": "6.9", "name": "Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Research"}]}

category_icrp_ct

Entity: SimpleCategorization

ICRP Cancer Types

 
      {"values": ["Not Site-Specific Cancer"], "full": [{"id": "3816", "value": "Not Site-Specific Cancer"}]}

category_rcdc

Entity: SimpleCategorization

Research, Condition, and Disease Categorization

 
      {"values": ["Prevention", "Clinical Trials and Supportive Activities", "Behavioral and Social Science", "Mind and Body", "Mental Health", "Clinical Research", "Complementary and Alternative Medicine", "Pediatric"], "full": [{"id": "558", "value": "Prevention"}, {"id": "508", "value": "Clinical Trials and Supportive Activities"}, {"id": "498", "value": "Behavioral and Social Science"}, {"id": "458", "value": "Mind and Body"}, {"id": "380", "value": "Mental Health"}, {"id": "507", "value": "Clinical Research"}, {"id": "430", "value": "Complementary and Alternative Medicine"}, {"id": "547", "value": "Pediatric"}]}

concepts

Array of < Entity: Concept >

Concepts describing the main topics of a clinical trial (note: automatically derived from the publication text using machine learning).

 
      [{"concept": "type 2 diabetes", "relevance": "0.6613533271499066"}, {"concept": "major adverse cardiovascular events", "relevance": "0.5938189233667946"}, {"concept": "adverse cardiovascular events", "relevance": "0.5781304951906274"}, {"concept": "cardiovascular events", "relevance": "0.5354345934681063"}, {"concept": "cardiovascular risk", "relevance": "0.5347364147008445"}, {"concept": "diabetes", "relevance": "0.4813957362803809"}, {"concept": "dulaglutide", "relevance": "0.42067410295695584"}, {"concept": "patients", "relevance": "0.4159796606977385"}, {"concept": "tirzepatide", "relevance": "0.4110294195515764"}, {"concept": "trials", "relevance": "0.4009629667128156"}, {"concept": "efficacy", "relevance": "0.3967648772262315"}, {"concept": "risk", "relevance": "0.385950719274986"}, {"concept": "safety", "relevance": "0.3671329335686628"}, {"concept": "participants", "relevance": "0.3633964434901934"}, {"concept": "events", "relevance": "0.3178925934144105"}, {"concept": "effect", "relevance": "0.31472978633378823"}, {"concept": "purpose", "relevance": "0.29572991807651383"}]

conditions

Array of < Literal: String >

List of medical conditions names, e.g. ‘Breast cancer’ or ‘Obesity’.

 
      ["Cognitive Therapy", "Primary Prevention", "Caregivers", "Mental Health Wellness 1", "Adolescent - Emotional Problem"]

date_imported_gbq

Literal: Timestamp

Timestamp when the clinical trial was last imported into BigQuery. Incremental changes can be determined using this field. Note, however at certain times all records may be reimported.

 
      "2020-08-05 03:00:30 UTC"

date_inserted

Literal: Timestamp

Date when the record was inserted into Dimensions.

 
      "2020-08-05 03:00:30 UTC"

end_date

Literal: String

End date of a clinical trial.

 
      "2021-03"

end_year

Literal: Integer

End year of the clinical trial.

 
      2021

funder_orgs

Array of < Literal: String >

GRID ID of organisations funding the clinical trial.

 
      ["grid.239864.2", "grid.65499.37"]

funding_details

Array of < Entity: Funding >

List of details regarding grants associated to the clinical trial.

 
      [{"grid_id": "grid.419635.c", "grant_id": "grant.2690176"}, {"grid_id": "grid.419635.c", "grant_id": "grant.6443089"}, {"grid_id": "grid.239864.2", "grant_id": null}, {"grid_id": "grid.65499.37", "grant_id": null}]

gender

Literal: String

The gender of the clinical trial subjects e.g. ‘Male’, ‘Female’ or ‘All’.

 
      "All"

id

Literal: String

Dimensions clinical trial ID.

 
      "NCT04114864"

interventions

Array of < Entity: Intervention >

Information about the clinical trial’s interventions according to the research plan or protocol created by the investigators.

 
      [{"arm_group_labels": "Dulaglutide", "description": "Administered SC", "type": "Drug", "name": "Dulaglutide", "other_names": "LY2189265"}, {"arm_group_labels": "Tirzepatide", "description": "Administered SC", "type": "Drug", "name": "Tirzepatide", "other_names": "LY3298176"}]

investigators

Array of < Entity: Investigator >

List of additional details regarding investigators, including affiliations and roles.

 
      [{"first_name": "Elizabeth", "last_name": "JHanson", "researcher_id": null, "affiliations": [{"affiliation": "Linneus University, Kalmar, Sweden", "grid_ids": [], "cities": [], "countries_territories": ["SE"], "states": []}]}, {"first_name": "Licia", "last_name": "Boccaletti", "researcher_id": "ur.014561655145.71", "affiliations": [{"affiliation": "Anziani e non solo soc. coop. soc", "grid_ids": [], "cities": ["3180445"], "countries_territories": ["IT"], "states": []}]}, {"first_name": "Frans", "last_name": "VanZoest", "researcher_id": null, "affiliations": [{"affiliation": "Stichting Vilans", "grid_ids": ["grid.438099.f"], "cities": ["2745912"], "countries_territories": ["NL"], "states": []}]}, {"first_name": "Valentina", "last_name": "Hlebec", "researcher_id": "ur.07551030232.17", "affiliations": [{"affiliation": "University of Ljubljana", "grid_ids": ["grid.8954.0"], "cities": ["3196359"], "countries_territories": ["SI"], "states": []}]}, {"first_name": "Agnes", "last_name": "Leu", "researcher_id": "ur.01352632125.37", "affiliations": [{"affiliation": "Stiftung Kalaidos Fachhochschule (Kalaidos FH)", "grid_ids": ["grid.449532.d"], "cities": ["2657896"], "countries_territories": ["CH"], "states": []}]}, {"first_name": "Eva", "last_name": "Jolly", "researcher_id": null, "affiliations": [{"affiliation": "Carers Trust, Print Rooms, 164-180 Union Street, London, SE1 0LN. Carers Trust will be co-ordinating the completion of the interventions for the clinical trials in the UK. All trials for the ME-WE project will be completed in England.", "grid_ids": ["grid.501037.0"], "cities": ["2643743"], "countries_territories": ["GB"], "states": []}]}]

linkout

Literal: String

Original URL for the clinical trial.

 
      "https://clinicaltrials.gov/show/NCT04114864"

mesh_terms

Array of < Literal: String >

Medical Subject Heading terms as used in PubMed.

 
      ["Nervous System Diseases", "Heredodegenerative Disorders, Nervous System", "Pathologic Processes", "Rett Syndrome", "Intellectual Disability", "Neurobehavioral Manifestations", "Syndrome", "Genetic Diseases, X-Linked", "Mental Retardation, X-Linked", "Neurologic Manifestations", "Disease", "Genetic Diseases, Inborn"]

organisation_details

Array of < Entity: Organisation >

List of details regarding organisations involved, e.g. as sponsors or collaborators.

 
      [{"raw_name": "Valentina Hlebec", "grid_id": null}, {"raw_name": "Anziani e non solo soc. coop. soc", "grid_id": null}, {"raw_name": "Stichting Vilans", "grid_id": "grid.438099.f"}, {"raw_name": "University of Ljubljana", "grid_id": "grid.8954.0"}, {"raw_name": "Linnaeus University, Nationellt kompetenscentrum anh\u00f6riga (Nka), (Swedish Family Care Competence Centre)", "grid_id": "grid.8148.5"}, {"raw_name": "Stiftung Kalaidos Fachhochschule (Kalaidos FH)", "grid_id": "grid.449532.d"}, {"raw_name": "Carers Trust, Print Rooms, 164-180 Union Street, London, SE1 0LN. Carers Trust will be co-ordinating the completion of the interventions for the clinical trials in the UK. All trials for the ME-WE project will be completed in England.", "grid_id": "grid.501037.0"}, {"raw_name": "Linneus University, Kalmar, Sweden", "grid_id": null}, {"raw_name": "Anziani e non solo soc. coop. soc", "grid_id": null}, {"raw_name": "Stichting Vilans", "grid_id": "grid.438099.f"}, {"raw_name": "University of Ljubljana", "grid_id": "grid.8954.0"}, {"raw_name": "Stiftung Kalaidos Fachhochschule (Kalaidos FH)", "grid_id": "grid.449532.d"}, {"raw_name": "Carers Trust, Print Rooms, 164-180 Union Street, London, SE1 0LN. Carers Trust will be co-ordinating the completion of the interventions for the clinical trials in the UK. All trials for the ME-WE project will be completed in England.", "grid_id": "grid.501037.0"}]

overall_status

Literal: String

Status of the trial as provided by the registry.

 
      "Completed"

phase

Literal: String

Phase of the clinical trial, as a string.

 
      "Phase 1/2"

primary_completion_date

Literal: String

Primary completion date provided by trial, year-month or just year.

 
      "2003-07"

primary_completion_year

Literal: Integer

Primary completion year provided by trial.

 
      "2003"

publication_ids

Array of < Literal: String >

List of Dimensions IDs of publications cited by the clinical trial.

 
      ["pub.1045250304", "pub.1113522247", "pub.1047486020", "pub.1009955273", "pub.1040139682", "pub.1030908595", "pub.1004866948", "pub.1027730547", "pub.1020556064", "pub.1035229386", "pub.1015646550", "pub.1058370884", "pub.1058267639"]

registry

Literal: String

The platform where the clinical trial has been registered, e.g. ‘ClinicalTrials.gov’ or ‘EU-CTR’.

 
      "ClinicalTrials.gov"

research_orgs

Array of < Literal: String >

GRID ID of organisations involved, e.g. as sponsors or collaborators.

 
      ["grid.422126.1", "grid.12082.39", "grid.8148.5", "grid.438099.f", "grid.501037.0", "grid.8954.0", "grid.1214.6", "grid.449532.d"]

researcher_ids

Array of < Literal: String >

Dimensions researchers IDs associated to the clinical trial.

 
      ["ur.07551030232.17", "ur.014561655145.71", "ur.01352632125.37"]

results_first_available_date

Literal: String

The date on which summary results information was first available.

secondary_id_details

Array of < Entity: SecondaryIdDetail >

Details about additional identifier, other than the organization’s Unique Protocol Identification Number that is assigned to the clinical study.

secondary_ids

Array of < Literal: String >

Identifiers, other than parent registry identification number, assigned to the study such as grant, contract numbers or an identification number assigned by another registry.

 
      ["CDR0000065549", "NCCTG-934655"]

start_date

Literal: String

Start date of a clinical trial.

 
      "2019-10"

start_year

Literal: Integer

Partitioning field

Start year of the clinical trial.

 
      2019

study_arms

Array of < Entity: StudyArm >

The groups or subgroups of participants that receives specific a set of interventions/treatments, or no intervention, according to the trial’s protocol.

 
      [{"type": "Experimental", "label": "LY3295668 Erbumine Escalation", "description": "LY3295668 Erbumine given orally."}, {"type": "Experimental", "label": "LY3295668 Erbumine + Topotecan + Cyclophosphamide Escalation", "description": "LY3295668 Erbumine given orally and topotecan and cyclophosphamide given intravenously (IV)."}, {"type": "Experimental", "label": "LY3295668 Erbumine Expansion", "description": "LY3295668 Erbumine given orally."}, {"type": "Experimental", "label": "LY3295668 Erbumine + Topotecan + Cyclophosphamide Expansion", "description": "LY3295668 Erbumine given orally and topotecan and cyclophosphamide given IV."}]

study_designs

Array of < Entity: StudyDesign >

Details regarding the design of a clinical trial.

 
      [{"allocation": "Randomized", "intervention_model": "Parallel Assignment", "primary_purpose": "Treatment", "masking": "None (Open Label)"}]

study_eligibility_criteria

Literal: String

Criteria for participation in the clinical study.

 
      "1. Relatives of patients;\n2. Aged >= 18 years;\n3. Is taking care of the patient, and will have a certain amount of time to take care of the patient every week for the next month (multiple caregivers, prefer the one with the longest care time);\n4. Recognizing that the patient's disease is incurable, the patient's survival is assessed by the attending physician according to KPS and other scales within six months, and not less than one month;\n5. Through the questionnaire evaluation, it is in a \" intentional state\";\n6. Good WeChat skills."

study_exclusion_criteria

Literal: String

Eligibility criteria for a person to not participate in clinical study.

study_inclusion_criteria

Literal: String

Eligibility criteria for a person to participate in clinical study.

study_maximum_age

Literal: String

Maximum age eligible for the study.

 
      "35"

study_minimum_age

Literal: String

Minimum age eligible for the study.

 
      "18"

study_outcome_measures

Array of < Entity: OutcomeMeasure >

List of measures of outcome associated to the clinical trial.

 
      [{"type": "primary", "measure": "Number of Participants with Dose Limiting Toxicities (DLTs)", "time_frame": "Baseline through Cycle 2 (28 Day Cycle)"}, {"type": "primary", "measure": "Overall Response Rate (ORR): Percentage of Participants Who Achieve Complete Response (CR) or Partial Response (PR)", "time_frame": "Baseline through Measured Progressive Disease (Estimated up to 5 Years)"}, {"type": "primary", "measure": "Duration of Response (DoR)", "time_frame": "Date of CR or PR to Date of Disease Progression or Death Due to Any Cause (Estimated up to 5 Years)"}, {"type": "secondary", "measure": "Pharmacokinetics (PK): Area Under the Concentration Time Curve (AUC) of LY3295668", "time_frame": "Cycle 1 Day 1 through Cycle 1 Day 15 (28 Day Cycles)"}, {"type": "secondary", "measure": "PK: AUC of LY3295668 in Combination with Topotecan and Cyclophosphamide", "time_frame": "Cycle 1 Day 1 through Cycle 1 Day 15 (28 Day Cycles)"}, {"type": "secondary", "measure": "Best Overall Response (BOR): Percentage of Participants with CR, PR, Stable Disease (SD), or Progressive Disease (PD)", "time_frame": "Baseline to Date of Objective Disease Progression (Estimated up to 5 Years)"}, {"type": "secondary", "measure": "Progression-Free Survival (PFS)", "time_frame": "Baseline to Objective Progression or Death Due to Any Cause (Estimated up to 5 Years)"}, {"type": "secondary", "measure": "Overall Survival (OS)", "time_frame": "Baseline to Date of Death from Any Cause (Estimated up to 6 Years)"}]

study_participants

Literal: Integer

The actual or estimated target number of participants.

 
      2500

study_type

Literal: String

The type of study associated to the clinical trial e.g. ‘Interventional’, ‘Observational’, etc.

 
      "Interventional study"

title

Literal: String

The title of the clinical trial.

 
      "A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers: a Randomized Control Trial in the Project H2020 ME-WE"

Auxiliary Entities

Affiliation

Field

Type

Description

affiliation

Literal: String

The raw affiliation string as seen on the source type.

cities

Array of < Literal: Integer >

The cities identified in the affiliation, as geoname IDs.

countries_territories

Array of < Literal: String >

The country/territories identified in the affiliation, as ISO-3166 alpha-2 codes.

grid_ids

Array of < Literal: String >

The assigned GRID IDs based on this affiliation.

states

Array of < Literal: String >

The states/regions identified in the affiliation, as ISO 3166-2 codes.

Altmetric

Field

Type

Description

id

Literal: String

Altmetrics record identifier

score

Literal: Integer

Altmetric Attention Score

ComplexSystematicCategorization

Field

Type

Description

first_level

Entity: SystematicCategoryLevel

First level of categorisation within the classification scheme.

second_level

Entity: SystematicCategoryLevel

Second level of categorisation within the classification scheme.

Concept

Field

Type

Description

concept

Literal: String

Normalized noun phrase describing a main topic within the document. Automatically derived using machine learning techniques.

relevance

Literal: Float

Relevance ranking of the normalized noun phrase within the document’s field of study.

Funding

Field

Type

Description

grant_id

Literal: String

The Dimensions grant ID, if identified.

grid_id

Literal: String

The GRID ID of the funder, if identified.

Intervention

Field

Type

Description

arm_group_labels

Literal: String

description

Literal: String

name

Literal: String

other_names

Literal: String

type

Literal: String

Investigator

Field

Type

Description

affiliations

Array of < Entity: Affiliation >

Affiliation details associated with the clinical investigator.

first_name

Literal: String

last_name

Literal: String

researcher_id

Literal: String

The Dimensions assigned researcher ID.

role

Literal: String

Role of the clinical investigator (ie. Principal Investigator, Study Chair/Director, Contact).

Organisation

Field

Type

Description

cities

Array of < Literal: Integer >

The cities identified in the affiliation, as GeoName identifiers.

countries_territories

Array of < Literal: String >

Country/territories identified in the affiliation, as ISO-3166 alpha-2 codes.

grid_id

Literal: String

The resolved GRID ID of the organisation.

provided_type

Literal: String

Type of the organisation involved, collected from the clinical trial registry.

raw_name

Literal: String

The organisation name as collected from the clinical trial registry.

states

Array of < Literal: String >

The states/regions identified in the affiliation, as ISO 3166-2 codes.

type

Literal: String

The type of organisation associated with the clinical trial (sponsor, collaborator, facility or affiliated).

OutcomeMeasure

Field

Type

Description

measure

Literal: String

Description of the measure.

time_frame

Literal: String

Details of the timeframe related to the measure.

type

Literal: String

Type assigned to the outcome measure e.g. ‘primary’, ‘secondary’, etc.

SecondaryIdDetail

Field

Type

Description

domain

Literal: String

Name or brief description of organization that issued the identifier.

id

Literal: String

An identifier(s) (ID), if any, other than the organization’s Unique Protocol Identification Number that is assigned to the clinical study.

type

Literal: String

A brief description of the type of identifier.

SimpleCategorization

Field

Type

Description

full

Array of < Entity: SimpleCategory >

A complete listing of category values, assigned to this particular record, including the unique Dimensions identifier associated with each catergory value.

values

Array of < Literal: String >

Listing of all catergory values assigned to this particular record.

SimpleCategory

Field

Type

Description

id

Literal: String

Dimensions specific identifier assigned to the category value.

value

Literal: String

Category value associated with the simple classification scheme.

StudyArm

Field

Type

Description

description

Literal: String

Description of the study arm.

label

Literal: String

Label assigned to the study arm.

type

Literal: String

Type of the study arm e.g. ‘Active Comparator’, ‘Experimental’, ‘No intervention’, etc.

StudyDesign

Field

Type

Description

allocation

Literal: String

intervention_model

Literal: String

masking

Literal: String

primary_purpose

Literal: String

SystematicCategorization

Field

Type

Description

codes

Array of < Literal: String >

Listing of all catergory specific codes assigned to this particular record.

full

Array of < Entity: SystematicCategory >

A complete listing of category values, assigned to this particular record, including the unique Dimensions identifier associated with each catergory value.

SystematicCategory

Field

Type

Description

code

Literal: String

Numeric or non-numeric category value code. Value is classification scheme specific.

id

Literal: String

Dimensions specific identifier assigned to the category value.

name

Literal: String

Individual category value description, excluding the classification scheme specific code prefix.

SystematicCategoryLevel

Field

Type

Description

codes

Array of < Literal: String >

A consolidated list of all category-specific codes at a particular classification level, assigned to this record.

full

Array of < Entity: SystematicCategory >

A listing of category values at a specific classification level, assigned to this particular record, including the unique Dimensions identifier associated with each category value.

VersionedCategories

Field

Type

Description

bra_v2020

Entity: SimpleCategorization

for_2020_v2022

Entity: ComplexSystematicCategorization

hra_v1

Entity: SimpleCategorization

hrcs_hc_v2020

Entity: SimpleCategorization

hrcs_rac_v2020

Entity: SystematicCategorization

icrp_cso_v2020

Entity: SystematicCategorization

icrp_ct_v2020

Entity: SimpleCategorization

rcdc_v2023

Entity: SimpleCategorization

deprecated rcdc_v1

Entity: SimpleCategorization

Deprecated in favor of: category_rcdc

Clinical Trials Deprecations

This section lists fields that have been deprecated and should no longer be used within queries. In time, deprecated fields will be removed from the data source’s corresponding schema in BigQuery.

Deprecated Fields

Field

Type

Description

category_sdg

Entity: SystematicCategorization

Deprecated with no recommended replacement.

category_uoa

Entity: SystematicCategorization

Deprecated with no recommended replacement.